Medicines produced by Gulf Pharmaceutical Industries (Julphar) are utilized to treat, manage, and prevent a wide spectrum of acute and chronic medical conditions across multiple therapeutic categories. Their extensive product portfolio includes treatments for cardiovascular diseases, diabetes (including recombinant human insulin and analog products), pain and inflammation, gastrointestinal disorders, respiratory ailments, central nervous system conditions, and anti-infective therapies. These pharmaceutical formulations are widely prescribed by healthcare professionals in hospitals and clinics across the Middle East, Africa, and international markets to improve patient outcomes, manage metabolic disorders, combat bacterial or viral infections, and support overall general healthcare and wellness maintenance.